10.1016/j.antiviral.2010.02.003
Journal article
2010-01-01T00:00:00+00:00
86
79 - 92
13
HCV, Novel targets, Innate immune response, Virus entry, NS2, NS3 helicase, NS4B, NS5A, Antivirals